Cytometric assessment of DNA damage induced by DNA topoisomerase inhibitors.
Exposure of cells to inhibitors of DNA topoisomerase I (topo I) or topoisomerase II (topo II) leads to DNA damage that often involves formation of DNA double-strand breaks (DSBs). DNA damage, particularly induction of DSBs, manifests by phosphorylation of histone H2AX on Ser-139 which is mediated by one of the protein kinases of the phosphoinositide kinase family, namely ATM, ATR, and/or DNA-PK. The presence of Ser-139 phosphorylated H2AX (gammaH2AX) is thus a reporter of DNA damage. This protocol describes quantitative assessment of gammaH2AX detected immunocytochemically in individual cells combined with quantification of cellular DNA content by cytometry. The bivariate analysis of gammaH2AX expression versus DNA content allows one to correlate DNA damage with the cell cycle phase or DNA ploidy. The protocol can also be used to assess activation (Ser-1981 phosphorylation) of ATM; this event also revealing DNA damage induced by topo I or topo II inhibitors. Examples where DNA damage was induced by topotecan (topo I) and etoposide (topo II) inhibitors are provided.
Darzynkiewicz
Zbigniew
Z
Brander Cancer Research Institute, New York Medical College, Valhalla, NY, USA.
Halicka
Dorota H
DH
Tanaka
Toshiki
T
D053903:DNA Breaks, Double-Stranded / Q000187:drug effects*; D004249:DNA Damage / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005434:Flow Cytometry / Q000295:instrumentation / Q000379:methods*; D006657:Histones / Q000235:genetics / Q000378:metabolism; D006801:Humans; D059004:Topoisomerase I Inhibitors
D004791:Enzyme Inhibitors; C468783:H2AX protein, human; D006657:Histones; D059004:Topoisomerase I Inhibitors